Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: WA NONMETROPOLITAN AREA — September 2026
Rural Washington regulatory pay climbs as biostatistics cools.
Regulatory Affairs Specialist advertised pay rose to a $118,235 metro median while Biostatistician pay fell to $147,800, even as statewide unemployment held near 4.9%.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- WA unemployment rate: 4.9% — Down from 5.0% in July, 2nd straight monthly decline
- Regulatory Affairs pay growth: $118,235 — Metro median, up moderately vs $104,000 national
- Biostatistician pay divergence: $147,800 — Metro down moderately vs $133,322 national, up moderately
- WA life sciences employment growth: +1.9% — 2024, vs -0.3% national decline
Key takeaways
Regulatory Affairs pay is climbing even as national rates hold flat.
Metro advertised median for Regulatory Affairs Specialist sits at $118,235, up moderately while the national median of $104,000 stays stable. This divergence suggests nonmetro and regional Washington employers are bidding up scarce regulatory talent to compete with Seattle-area biotech, not simply tracking national inflation.
Biostatistician pay is cooling locally while national demand heats up.
Metro median fell to $147,800 even as the national median rose to $133,322, narrowing a gap that typically favors Washington employers. Softening local demand for this role may reflect project-based hiring pullback or greater reliance on CRO-provided biostatistics rather than in-house headcount.
Clinical Research Associate pay signals a tightening trial-support market.
Both metro ($84,620) and national ($90,956) medians moved up significantly this month, consistent with sustained clinical trial activity despite broader layoff headlines in biopharma. Nonmetro employers running local trial sites should expect sharper competition for CRA talent against better-funded metro sponsors.
Lab Technician pay divergence hints at a structural, not cyclical, shift.
Metro median held stable at $57,200 while the national median dropped moderately to $47,402, widening the premium nonmetro Washington employers must pay. Persistent entry-level scarcity in rural labor markets may be pushing wages up locally even as national demand for the role softens.
Median advertised pay by role — WA NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $83,387 | $132,000 | $151,115 | Significant increase | $131,354 |
| Clinical Research Associate | $80,763 | $84,620 | $100,523 | Significant increase | $90,956 |
| Lab Technician * | $46,540 | $57,200 | $67,954 | Stable | $47,402 |
| Regulatory Affairs Specialist | $93,409 | $118,235 | $122,072 | Moderate increase | $104,000 |
| Clinical Data Manager * | $100,327 | $120,009 | $130,356 | Stable | $123,031 |
| Biostatistician * | $111,745 | $147,800 | $158,319 | Moderate decline | $133,322 |
| Validation Engineer * | $96,427 | $114,438 | $126,203 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rural Washington labor markets remain constrained by statewide unemployment holding near 4.9% and a thinning pool of credentialed scientific and manufacturing talent, even as the state's life sciences sector grew headcount 1.9% in 2024 against a 0.3% national decline. Outside the Seattle and Spokane metro cores, nonmetro counties see less direct biotech investment but compete for the same regulatory, quality, and bioprocess talent pulled toward Seattle MSA pharma manufacturing R&D roles, which grew 60% year-over-year with median pay near $190,500.
What it means
Thin nonmetro labor supply raises the cost and timeline risk of building GMP or quality staff locally, reinforcing the case for routing specialized manufacturing and analytical work to established CDMOs like Spokane's Jubilant HollisterStier rather than standing up new internal capacity. Regulatory and CMC talent scarcity statewide means nonmetro employers competing against Seattle-area total compensation packages will struggle to retain mid-career staff without differentiated pay or remote/hybrid flexibility tied to metro-benchmarked roles. Consider reviewing whether nonmetro regulatory affairs and manufacturing compensation bands track Seattle MSA movement closely enough to prevent quiet attrition toward higher-paying urban employers.
Looking ahead
Early indicator: Washington's 110 WARN notices in 2026 have skewed toward agriculture, fulfillment, and now healthcare, with MultiCare's 138-worker notice in September signaling spillover risk into nonmetro health systems that compete for the same clinical and lab talent pool.
Worth watching: Statewide unemployment has ticked down two consecutive months to 4.9%, but nonmetro counties typically lag state recovery; watch October county-level data (due ~October 20) for whether rural labor supply is actually loosening or merely tracking a statewide statistical improvement.
Emerging pressure point: CDMO hiring at Jubilant HollisterStier and continued Seattle MSA manufacturing R&D growth (60% YoY) may pull nonmetro quality and manufacturing staff toward metro employers offering higher advertised pay, accelerating build-vs-outsource decisions for nonmetro facilities.
Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) alongside 64% of surveyed biopharma orgs still actively recruiting suggests displaced specialized talent may surface in regional candidate pools; nonmetro employers should monitor whether this eases regulatory and CMC scarcity locally.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.